Patent ID: 8821876

Claim:
A method of identifying a subject infected with a respiratory virus comprising: a) determining gene expression levels of panviral signature genes from a peripheral blood cell sample of the subject, wherein the panviral signature genes consist of ATF3, CXCL10, DDX58, HERC5, IFI27, IFI44, IFI44L, IFI6, IFIT1, IFIT2, IFIT3, ISG15, LAMP3, LOC26010, LOC727996, LY6E, MX1, OAS1, OAS2, OAS3, OASL, PML, RSAD2, RTP4, SEPT4, SERPING1, SIGLEC1, TNFAIP6, and XAF1, wherein determining comprises a method selected from the group consisting of assaying the sample with an array comprising a plurality of nucleic acid oligomers, real time PCR, assaying the sample with an array comprising a plurality of antibodies, and LC/MS; b) comparing the gene expression levels of the panviral signature genes of step a) to standard gene expression levels for the panviral signature genes, wherein a difference between the levels of expression of the panviral signature genes and the standard gene expression levels is indicative of a subject infected with a respiratory virus; and c) administering an effective amount of an anti-viral therapeutic agent to the subject.